Megan M. Kaneda

3.5k total citations · 1 hit paper
20 papers, 1.7k citations indexed

About

Megan M. Kaneda is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Megan M. Kaneda has authored 20 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 6 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Megan M. Kaneda's work include Immune cells in cancer (9 papers), Phagocytosis and Immune Regulation (5 papers) and Immune Cell Function and Interaction (3 papers). Megan M. Kaneda is often cited by papers focused on Immune cells in cancer (9 papers), Phagocytosis and Immune Regulation (5 papers) and Immune Cell Function and Interaction (3 papers). Megan M. Kaneda collaborates with scholars based in United States, Japan and United Kingdom. Megan M. Kaneda's co-authors include Judith A. Varner, Samuel A. Wickline, Gregory M. Lanza, Philippe Foubert, Abraham V. Nguyen, Shelton D. Caruthers, Michael C. Schmid, Douglas Hanahan, Nesrine I. Affara and Betty Chang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Blood.

In The Last Decade

Megan M. Kaneda

18 papers receiving 1.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bruton Tyrosine Kinase–Dependent Immune Cell Cross-talk Drives Pancreas Cancer

2015 381 citations Andrew J. Gunderson, Megan M. Kaneda et al. Cancer Discovery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Megan M. Kaneda United States	13	768	615	510	180	161	20	1.7k
Paul D. Kassner United States	23	651 0.8×	335 0.5×	945 1.9×	97 0.5×	261 1.6×	46	2.6k
Г. В. Шаронов Russia	23	579 0.8×	449 0.7×	729 1.4×	181 1.0×	131 0.8×	66	1.7k
Jingya Guo China	13	1.2k 1.5×	925 1.5×	481 0.9×	357 2.0×	136 0.8×	23	1.9k
Geulah Livshits United States	13	425 0.6×	433 0.7×	877 1.7×	87 0.5×	185 1.1×	18	1.5k
Roberto Rangel United States	25	389 0.5×	443 0.7×	940 1.8×	94 0.5×	283 1.8×	54	1.8k
James Trager United States	16	640 0.8×	622 1.0×	1.1k 2.1×	72 0.4×	80 0.5×	50	2.2k
Harry Leung Canada	12	477 0.6×	491 0.8×	528 1.0×	346 1.9×	233 1.4×	12	1.8k
Lupeng Ye China	17	362 0.5×	509 0.8×	966 1.9×	77 0.4×	113 0.7×	35	1.4k
Nelly Kieffer Luxembourg	29	383 0.5×	344 0.6×	1.0k 2.0×	189 1.1×	310 1.9×	61	2.9k
Douglas K. Ferris United States	24	474 0.6×	764 1.2×	1.8k 3.4×	186 1.0×	231 1.4×	54	2.7k

Countries citing papers authored by Megan M. Kaneda

Since Specialization

Citations

This map shows the geographic impact of Megan M. Kaneda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Megan M. Kaneda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Megan M. Kaneda more than expected).

Fields of papers citing papers by Megan M. Kaneda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Megan M. Kaneda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Megan M. Kaneda. The network helps show where Megan M. Kaneda may publish in the future.

Co-authorship network of co-authors of Megan M. Kaneda

This figure shows the co-authorship network connecting the top 25 collaborators of Megan M. Kaneda. A scholar is included among the top collaborators of Megan M. Kaneda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Megan M. Kaneda. Megan M. Kaneda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Krishnamoorthy, Mithunah, Ruth Seelige, Christopher R. Brown, et al.. (2025). Maplirpacept: a CD47 decoy receptor with minimal red blood cell binding and robust anti-tumor efficacy. Frontiers in Immunology. 16. 1518787–1518787.

Christo, Susan N., Thomas N. Burn, Nadia S. Kurd, et al.. (2024). Dual CD47 and PD‐L1 blockade elicits anti‐tumor immunity by intratumoral CD8⁺ T cells. Clinical & Translational Immunology. 13(11). e70014–e70014. 1 indexed citations

Krishnamoorthy, Mithunah, Natasja Nielsen Viller, Mark Wong, et al.. (2023). The CD47-Blocking Immune Checkpoint Inhibitor Maplirpacept Does Not Interfere with Blood Transfusion Compatibility Testing. Blood. 142(Supplement 1). 4037–4037.

Schmid, Michael C., Sang Won Kang, Hui Chen, et al.. (2022). PI3Kγ stimulates a high molecular weight form of myosin light chain kinase to promote myeloid cell adhesion and tumor inflammation. Nature Communications. 13(1). 1768–1768. 15 indexed citations

Li, Jie, Megan M. Kaneda, Jun Ma, et al.. (2020). PI3K-gamma Inhibition Suppresses Accumulation of Glioblastoma-associated Microglia to Recapitulate the Microenvironment of Exceptional Responders. Neurosurgery. 67(Supplement_1). 1 indexed citations

Schmid, Michael C., Samia Q. Khan, Megan M. Kaneda, et al.. (2018). Integrin CD11b activation drives anti-tumor innate immunity. Nature Communications. 9(1). 5379–5379. 197 indexed citations

Foubert, Philippe, Megan M. Kaneda, & Judith A. Varner. (2017). PI3Kγ Activates Integrin α4 and Promotes Immune Suppressive Myeloid Cell Polarization during Tumor Progression. Cancer Immunology Research. 5(11). 957–968. 69 indexed citations

Kaneda, Megan M., Kunal Patel, Jing Wang, et al.. (2017). OS06.7 PI-3Kγ inhibition suppresses glioblastoma tumorigenicity through disruption of an IL11-STAT3-MYC signaling axis between microglia and glioblastoma. Neuro-Oncology. 19(suppl_3). iii12–iii12. 1 indexed citations

Sato-Kaneko, Fumi, Shiyin Yao, Shannon Zhang, et al.. (2017). Combination immunotherapy with TLR agonists and checkpoint inhibitors suppresses head and neck cancer. JCI Insight. 2(18). 230 indexed citations

10.

Kaneda, Megan M., Paola Cappello, Abraham V. Nguyen, et al.. (2016). Macrophage PI3Kγ Drives Pancreatic Ductal Adenocarcinoma Progression. Cancer Discovery. 6(8). 870–885. 236 indexed citations

11.

Gunderson, Andrew J., Megan M. Kaneda, Takahiro Tsujikawa, et al.. (2015). Bruton Tyrosine Kinase–Dependent Immune Cell Cross-talk Drives Pancreas Cancer. Cancer Discovery. 6(3). 270–285. 381 indexed citations breakdown →

12.

Li‐Byarlay, Hongmei, Yang Li, Hume Stroud, et al.. (2013). RNA interference knockdown of DNA methyl-transferase 3 affects gene alternative splicing in the honey bee. Proceedings of the National Academy of Sciences. 110(31). 12750–12755. 182 indexed citations

13.

Kaneda, Megan M., Yo Sasaki, Gregory M. Lanza, Jeffrey Milbrandt, & Samuel A. Wickline. (2010). Mechanisms of nucleotide trafficking during siRNA delivery to endothelial cells using perfluorocarbon nanoemulsions. Biomaterials. 31(11). 3079–3086. 48 indexed citations

14.

Southworth, Richard, Megan M. Kaneda, Junjie Chen, et al.. (2009). Renal vascular inflammation induced by Western diet in ApoE-null mice quantified by 19F NMR of VCAM-1 targeted nanobeacons. Nanomedicine Nanotechnology Biology and Medicine. 5(3). 359–367. 49 indexed citations

15.

Kaneda, Megan M., Shelton D. Caruthers, Gregory M. Lanza, & Samuel A. Wickline. (2009). Perfluorocarbon Nanoemulsions for Quantitative Molecular Imaging and Targeted Therapeutics. Annals of Biomedical Engineering. 37(10). 1922–1933. 145 indexed citations

16.

Alford, Shannon K., Megan M. Kaneda, Bradley K. Wacker, & Donald L. Elbert. (2008). Endothelial cell migration in human plasma is enhanced by a narrow range of added sphingosine 1‐phosphate: Implications for biomaterials design. Journal of Biomedical Materials Research Part A. 88A(1). 205–212. 10 indexed citations

17.

Wacker, Bradley K., Evan A. Scott, Megan M. Kaneda, Shannon K. Alford, & Donald L. Elbert. (2006). Delivery of Sphingosine 1-Phosphate from Poly(ethylene glycol) Hydrogels. Biomacromolecules. 7(4). 1335–1343. 41 indexed citations

18.

Hughes, Shannon K., Bradley K. Wacker, Megan M. Kaneda, & Donald L. Elbert. (2005). Fluid Shear Stress Modulates Cell Migration Induced by Sphingosine 1-Phosphate and Vascular Endothelial Growth Factor. Annals of Biomedical Engineering. 33(8). 1003–1014. 19 indexed citations

19.

Nishida, Kazuhiro, Shigeru Kinoshita, Norihiko Yokoi, et al.. (1994). Immunohistochemical localization of transforming growth factor-beta 1, -beta 2, and -beta 3 latency-associated peptide in human cornea.. PubMed. 35(8). 3289–94. 61 indexed citations

20.

Takeda, Isao, et al.. (1988). Double-staining analysis of mononuclear cells infiltrating rejected kidney.. PubMed. 20(2). 211–3. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact